CRYSTALLINE FORMS OF A 3-PYRROLE SUBSTITUTED 2-INDOLINONE MALATE SALT
    3.
    发明公开
    CRYSTALLINE FORMS OF A 3-PYRROLE SUBSTITUTED 2-INDOLINONE MALATE SALT 有权
    3-吡咯取代的2-吲哚酮苹果酸盐的结晶形式

    公开(公告)号:EP2342195A2

    公开(公告)日:2011-07-13

    申请号:EP09786058.9

    申请日:2009-07-24

    申请人: Medichem, S.A.

    CPC分类号: C07D403/06

    摘要: Disclosed are crystalline polymorphic forms of the malic acid salt of (Z)-N-[2- (diethylamino)ethyl]-5-[(5-fluoro-l,2-dihydro-2-oxo-3H-indol-3-yliden)methyl]-2,4- dimethyl-1H-pyrrole-3-carboxamide, sunitinib malate, including crystalline Forms III, IV, V, VI and VII. Also disclosed are processes for preparing crystalline polymorphic forms of sunitinib malate and pharmaceutical compositions comprising sunitinib malate.

    摘要翻译: 公开了(Z)-N- [2-(二乙基氨基)乙基] -5 - [(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-基) 甲基] -2,4-二甲基-1H-吡咯-3-甲酰胺,苹果酸舒尼替尼,包括结晶形式III,IV,V,VI和VII。 还公开了制备苹果酸舒尼替尼的结晶多晶型物和包含苹果酸舒尼替尼的药物组合物的方法。

    SOLID FORMS OF AN N-(PHENYLMETHYL)PROPANAMIDE DERIVATIVE AND PROCESSES OF PREPARATION
    5.
    发明公开
    SOLID FORMS OF AN N-(PHENYLMETHYL)PROPANAMIDE DERIVATIVE AND PROCESSES OF PREPARATION 审中-公开
    FESTE FORMEN EINES N-(PHENYLMETHYL)Propanamid-DERIVATS UND HERSTELLUNGSVERFAHRENDAFÜR

    公开(公告)号:EP2462107A1

    公开(公告)日:2012-06-13

    申请号:EP10755114.5

    申请日:2010-08-05

    申请人: Medichem, S.A.

    IPC分类号: C07C237/22

    CPC分类号: C07C237/22

    摘要: Disclosed are solid Forms, and corresponding mixtures, of the anti-epileptic agent lacosamide (I). Also disclosed is a mixture of lacosamide enantiomers crystallized in a conglomerate Form and the use thereof in providing enantiomerically enriched lacosamide, preferably lacosamide enriched with the (R)- enantiomer of lacosamide.

    摘要翻译: 本发明涉及抗癫痫剂拉科酰胺(I)的固体形式。 本发明还涉及拉莫糖的固体形式的混合物。 本发明还涉及以聚集体形式结晶的lacosamide对映异构体的混合物及其在提供对映异构体富集的lacosamide,优选lacosamide的(R) - 对映异构体富集的lacosamide)中的用途。